Thus, the APP/PS1 transgenic mouse model is quite suitable for observing the effects of AD preventive drugs on the elevation of amyloid and its consequences, whether as initiating events or key elements facilitating AD progress in the early stages of AD 4, 18, 19, 41. The gene discussed is PSEN1; the disease is Alzheimer disease.